geropharm.com — September 2026 traffic, keywords & AI visibility

geropharm.com draws an estimated 420 visits a month from search engines. Effectively all of it is organic — about 420 visits from unpaid results. Spread across 27 ranking keywords, that averages roughly 16 organic visits per keyword.

On our AI visibility scale geropharm.com earns 59 of 100 points, a grade D. It takes full marks for LLMS.txt. The biggest gap is SEO health, at 0 of 20 points (0/100), worth 20 points if closed. It also loses points on Crawlability (0/10), Company profile (19/25) and Structured data (0/5).

The llms.txt on geropharm.com runs to 77 lines (3,454 characters) across 12 sections, last generated in May 2026. It introduces the site as "Geropharm". It tells AI engines the business works in Pharmaceuticals, Drug Development and Clinical Research. It describes 3 products, including Geropharm Insulin Line, Clinical Trial Services and Patient Support Kits. Services it lists include Regulatory Submission Support and Drug Safety Monitoring. Technologies it mentions include HTTPS. The keywords it claims start with "pharmaceuticals", "healthcare", "drug development" and "clinical trials".

# Geropharm

## About
Geropharm works in the core areas of drug development and biopharmaceutical manufacturing. The team runs clinical trials that follow standard regulatory paths and produces medicines aimed at everyday healthcare needs. Their main effort goes into creating treatments that doctors can actually use without extra complications. Over time they have built processes that keep production steady while meeting safety checks at each stage.

Hospitals and clinics form the main customer base along with support programs that help patients stay on their prescribed courses. Geropharm also works with other drug makers on joint research projects when it makes sense for both sides. The approach stays practical rather than flashy, concentrating on reliable supply and clear documentation for regulators. This has helped them stay competitive against bigger names without overextending resources.

Value comes from steady improvements in how trials are run and how products reach the market faster than average timelines. They keep an eye on patient feedback loops to adjust formulations when real-world data shows small issues. Overall the company positions itself as a steady supplier rather than a headline-grabbing innovator, which fits the needs of many regional healthcare systems looking for dependable partners.

**Areas of Work:** Pharmaceuticals, Drug Development, Clinical Resear

Google lists geropharm.com for about 27 keywords, which together bring an estimated 420 organic visits a month.

The latest technical audit of geropharm.com scored 0 out of 100 overall. The audit makes 12 recommendations in all, and 4 of the 4 listed first are rated high priority or critical.

Geropharm's company profile names https://www.pharmalex.com, https://www.pfizer.com, https://www.merck.com and https://www.abbvie.com as competitors. Its own llms.txt adds https://www.amsa.com and https://www.boehringer-ingelheim.com. Outside its market, the domains ranked closest to it in our worldwide ranking are mmbrindes.com.br, statscrew.com, krackattacks.com and handnn.com.

https://www.pharmalex.com

https://www.pfizer.com

https://www.merck.com

https://www.abbvie.com

https://www.amsa.com

https://www.boehringer-ingelheim.com